Результаты поиска - Ran Reshef

Отмена результатов
  1. 1
    Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report

    Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report по Tyler Ruemmele, Rodney Macedo, Mark N. Stein, Hei Ton Chan, Markus Y. Mapara, Céline Jacquemont, Ran Reshef

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients

    Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients по Ran Reshef, Marlise R. Luskin, Malek Kamoun, Saran Vardhanabhuti, J E Tomaszewski, Edward A. Stadtmauer, David Porter, Daniel F. Heitjan, De.E. Tsai

    Опубликовано 2011
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation

    Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation по Alex Ganetsky, Arpita Shah, Todd A. Miano, W-T Hwang, J. He, Alison W. Loren, Elizabeth O. Hexner, Noelle V. Frey, David L. Porter, Ran Reshef

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

    Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★ по Ran Reshef, Saran Vardhanabhuti, Marlise R. Luskin, Daniel F. Heitjan, Denis Hadjiliadis, Simin Göral, Karen Krok, Lee R. Goldberg, David Porter, Edward A. Stadtmauer, Daniel Tsai

    Опубликовано 2011
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT

    NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT по Mobin Karimi, Jerrod L. Bryson, Lee P. Richman, Andrew D. Fesnak, Theresa M. Leichner, Atsushi� Satake, Robert H. Vonderheide, David H. Raulet, Ran Reshef, Taku Kambayashi

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

    Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis по Ryan H. Moy, Austin P. Huffman, Lee P. Richman, Lisa Crisalli, Ximi K. Wang, James A. Hoxie, Rosemarie Mick, Stephen G. Emerson, Yi Zhang, Robert H. Vonderheide, David Porter, Ran Reshef

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

    The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder по Marlise R. Luskin, Daniel S. Heil, Kay See Tan, Soo Jin Choi, Edward A. Stadtmauer, Stephen J. Schuster, David L. Porter, Robert H. Vonderheide, Adam Bagg, Daniel F. Heitjan, Donald E. Tsai, Ran Reshef

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity

    Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity по Shan He, Yongnian Liu, Lijun Meng, Hongxing Sun, Ying Wang, Yun Ji, Janaki Purushe, Pan Chen, Changhong Li, Jozef Madžo, Jean–Pierre J. Issa, Jonathan Soboloff, Ran Reshef, Bethany B. Moore, Luca Gattinoni, Yi Zhang

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Early Donor Chimerism Levels Predict Relapse and Survival after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning

    Early Donor Chimerism Levels Predict Relapse and Survival after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning по Ran Reshef, Elizabeth O. Hexner, Alison W. Loren, Noelle V. Frey, Edward A. Stadtmauer, Selina M. Luger, James K. Mangan, Saar Gill, Pavel Vassilev, Kathryn A. Lafferty, Jacqueline Smith, Vivianna M. Van Deerlin, Rosemarie Mick, David Porter

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

    Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis по Éric Lefebvre, Graeme Moyle, Ran Reshef, Lee P. Richman, Melanie Thompson, Hong Feng, Hsin-l Chou, Taishi Hashiguchi, Craig F. Plato, Dominic Poulin, Toni L. Richards, Hiroyuki Yoneyama, Helen Jenkins, Grushenka H.I. Wolfgang, Scott L. Friedman

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 Study

    Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 Study по Matthew J. Frigault, Richard T. Maziarz, Jae H. Park, Aleksandr Lazaryan, Nirav N. Shah, Jakub Svoboda, Lazaros J. Lekakis, Ran Reshef, Christine L. Phillips, Lea Burke, Jing Lei, Michael A. Pratta, Rodica Morariu-Zamfir, John F. DiPersio

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial

    PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial по Mark N. Stein, Ecaterina E. Dumbrava, Benjamin A. Teply, Usama Gergis, Martin Guiterrez, Ran Reshef, Sumit K. Subudhi, Céline Jacquemont, Joseph Senesac, J. Henri Bayle, Charity D. Scripture, Monica Sheila Chatwal, Mehmet Asım Bilen, Walter M. Stadler, Carlos Becerra

    Опубликовано 2024
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation

    The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation по Lijun Meng, Zhenjiang Bai, Shan He, Kazuhiro Mochizuki, Yongnian Liu, Janaki Purushe, Hongxing Sun, Jian Wang, Hideo Yagita∥, Shin Mineishi, Henry C. Fung, Gregory A. Yanik, Roberto Caricchio, Xiaoxuan Fan, Lisa Crisalli, Elizabeth O. Hexner, Ran Reshef, Yanyun Zhang, Yi Zhang

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

    Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease по Ran Reshef, Selina M. Luger, Elizabeth O. Hexner, Alison W. Loren, Noelle V. Frey, Sunita D. Nasta, Steven C. Goldstein, Edward A. Stadtmauer, Jacqueline Smith, S. Bailey, Rosemarie Mick, Daniel F. Heitjan, Stephen G. Emerson, James A. Hoxie, Robert H. Vonderheide, David Porter

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

    High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning по Ran Reshef, Austin P. Huffman, Amy Gao, Marlise R. Luskin, Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Taku Kambayashi, Alison W. Loren, Selina M. Luger, James K. Mangan, Sunita D. Nasta, Lee P. Richman, Mary Sell, Edward A. Stadtmauer, Robert H. Vonderheide, Rosemarie Mick, David Porter

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

    Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide по Shannon R. McCurdy, Mei-Jie Zhang, Andrew St. Martin, Monzr M. Al Malki, Asad Bashey, Sameh Gaballa, Daniel A. Keesler, Mehdi Hamadani, Maxim Norkin, Miguel‐Angel Perales, Ran Reshef, Vanderson Rocha, Rizwan Romee, Melhem Solh, Álvaro Urbano-Ispízua, Edmund K. Waller, Ephraim J. Fuchs, Mary Eapen

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    KarMMa-2 Cohort 2a: Efficacy and Safety of Idecabtagene Vicleucel in Clinical High-Risk Multiple Myeloma Patients with Early Relapse after Frontline Autologous Stem Cell Transplantation

    KarMMa-2 Cohort 2a: Efficacy and Safety of Idecabtagene Vicleucel in Clinical High-Risk Multiple Myeloma Patients with Early Relapse after Frontline Autologous Stem Cell Transplant... по Saad Z. Usmani, Krina K. Patel, Parameswaran Hari, Jesús G. Berdeja, Melissa Alsina, Ravi Vij, Noopur Raje, Xavier Leleu, Madhav V. Dhodapkar, Ran Reshef, Anna Truppel-Hartmann, Debashree Basudhar, Ethan Thompson, Xirong Zheng, Revathi Ananthakrishnan, Chiara Greggio, Linda Favre-Kontula, Lars Sternas, Jesús F. San Miguel

    Опубликовано 2022
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

    Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol по Sarah Nikiforow, Jennifer Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu‐Arja, Kris M. Mahadeo, Wen‐Kai Weng, Koen van Besien, David M. Loeb, Sunita D. Nasta, Eneida R. Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin T. Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan E. Prockop

    Опубликовано 2024
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

    Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation по Neema P. Mayor, Tao Wang, Stephanie J. Lee, Michelle Kuxhausen, Cynthia Vierra‐Green, Dominic J. Barker, Jeffery J. Auletta, Vijaya Raj Bhatt, Shahinaz M. Gadalla, Loren Gragert, Yoshihiro Inamoto, Gerald P. Morris, Sophie Paczesny, Ran Reshef, Olle Ringdén, Bronwen E. Shaw, Peter J. Shaw, Stephen R. Spellman, Steven G. E. Marsh

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

    Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Tria... по Marcelo C. Pasquini, Brent R. Logan, Richard J. Jones, Amin M. Alousi, Frederick R. Appelbaum, Javier Bolaños‐Meade, Mary E.D. Flowers, Sergio Giralt, Mary M. Horowitz, David A. Jacobsohn, John Koreth, John E. Levine, Leo Luznik, Richard T. Maziarz, Adam Mendizabal, Steven Z. Pavletic, Miguel‐Angel Perales, David Porter, Ran Reshef, Daniel J. Weisdorf, Joseph H. Antin

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: